The biotechnology company secured regulatory approval to advance two investigational drug studies, including a phase one ...
D3 Bio, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two ...
Considering a U.S. vacation during a pandemic? Medical pros lay out the best practices at restaurants, hotels, and public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback